Investing.com - argenx ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
argenx ADR announced earnings per share of $-3.81 on revenue of $85.18M. Analysts polled by Investing.com anticipated EPS of $-4.94 on revenue of $40.39M.
argenx ADR shares are up 4.22% from the beginning of the year, still down 5.78% from its 52 week high of $387.36 set on July 28. They are outperforming the Nasdaq which is down 23.52% from the start of the year.
argenx ADR shares gained 1.99% in intra-day trade following the report.
argenx ADR follows other major Healthcare sector earnings this month
argenx ADR's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar